Table of Contents
Angiotensin-converting enzyme (ACE) inhibitors are a cornerstone in the management of hypertension and heart failure. Proper dosing is essential to maximize therapeutic benefits while minimizing adverse effects. Dosing guidelines vary based on patient populations, including age, renal function, and comorbidities.
General Principles of ACE Inhibitor Dosing
Initial doses are typically low to assess tolerance. Gradual titration is recommended to reach target doses, which are often based on clinical trials. Monitoring renal function and serum potassium is crucial during therapy.
Dosing in Adult Patients
For most adult patients, starting doses are:
- Enalapril: 5 mg once daily
- Lisinopril: 10 mg once daily
- Captopril: 25 mg two to three times daily
Target doses are generally:
- Enalapril: 10-20 mg twice daily
- Lisinopril: 20-40 mg once daily
- Captopril: 50 mg three times daily
Dosing in Elderly Patients
Elderly patients often require lower initial doses due to increased sensitivity and risk of hypotension. Close monitoring is necessary. Typical starting doses include:
- Enalapril: 2.5-5 mg once daily
- Lisinopril: 5-10 mg once daily
Adjust doses gradually based on response and tolerability.
Dosing in Patients with Renal Impairment
Renal function significantly affects ACE inhibitor dosing. In patients with impaired renal function, start with lower doses and titrate cautiously. For example:
- Creatinine clearance <30 mL/min: Start with half the usual dose
- Monitor serum creatinine and potassium regularly
Dosing in Patients with Heart Failure
ACE inhibitors are vital in heart failure management. Initiate therapy at low doses to prevent hypotension, then titrate upward as tolerated. Typical starting doses:
- Enalapril: 2.5 mg twice daily
- Lisinopril: 5 mg once daily
Target doses are usually:
- Enalapril: 10-20 mg twice daily
- Lisinopril: 20-40 mg once daily
Special Considerations
Patients with bilateral renal artery stenosis or volume depletion require cautious dosing. Always assess volume status and renal function before initiation and during therapy.
Conclusion
Proper dosing of ACE inhibitors tailored to individual patient characteristics enhances efficacy and safety. Regular monitoring and dose adjustments are essential components of successful therapy.